Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID‐19 patients: A systematic review and meta‐analysis

R Marcec, VM Dodig, I Radanovic… - Reviews in medical …, 2022 - Wiley Online Library
Intravenous immunoglobulin (IVIg) therapy has been suggested as a potential treatment
option for hospitalised COVID‐19 patients. The aim of this systematic review and meta …

Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources

DJ Sullivan, M Franchini, MJ Joyner… - Nature …, 2022 - nature.com
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from
therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …

COVID-19 therapeutics

D Focosi, M Franchini, F Maggi… - Clinical Microbiology …, 2024 - Am Soc Microbiol
Since the emergence of COVID-19 in 2020, an unprecedented range of therapeutic options
has been studied and deployed. Healthcare providers have multiple treatment approaches …

Hyperimmune Plasma and Immunoglobulins against COVID-19: a narrative review

M Franchini, D Focosi - Life, 2024 - mdpi.com
Since late 2019, the new SARS-CoV-2 virus belonging to the Coronaviridae family has been
responsible for COVID-19 pandemic, a severe acute respiratory syndrome. Several antiviral …

Passive antibody therapy in emerging infectious diseases

X Yang - Frontiers of Medicine, 2023 - Springer
The epidemic of corona virus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome Coronavirus 2 and its variants of concern (VOCs) has been ongoing for over 3 …

Convalescent plasma versus hyperimmune immunoglobulins

D Focosi, M Franchini, E Nicastri… - Clinical Infectious …, 2023 - academic.oup.com
TO THE EDITOR—We read with interest the manuscript by Ando and colleagues in which
the authors showed a high efficacy of amoxicillin-based regimens for syphilis in people with …

Serum anti‐Spike immunoglobulin G levels in random blood donors in Italy: High‐titre convalescent plasma is easier than ever to procure

D Focosi, S Meschi, S Coen, MC Iorio… - Vox …, 2023 - Wiley Online Library
Background and Objectives COVID‐19 convalescent plasma (CCP) has retained potency
and clinical efficacy against SARS‐CoV‐2 and is currently of utmost value for seronegative …

[PDF][PDF] Analysis of anti-Omicron neutralizing antibody titers in different convalescent plasma sources

D Focosi, M Franchini, MJ Joyner, A Casadevall… - medRxiv, 2021 - scienceopen.com
Analysis of anti-Omicron neutralizing antibody titers in different convalescent plasma sources
Page 1 1 Analysis of anti-Omicron neutralizing antibody titers in different convalescent plasma …

Immune Plasma for the Treatment of COVID-19: Lessons Learned so far

H Schrezenmeier, S Hoffmann, H Hofmann… - …, 2023 - thieme-connect.com
COVID-19 convalescent plasma (CCP) has been explored as one of the treatment options
for COVID-19. Results of many cohort studies and clinical trials have been recently …

Passive immunotherapies for the next influenza pandemic

D Focosi, M Franchini, JW Senefeld… - Reviews in Medical …, 2024 - Wiley Online Library
Influenzavirus is among the most relevant candidates for a next pandemic. We review here
the phylogeny of former influenza pandemics, and discuss candidate lineages. After briefly …